[1] 刘阳, 陈冉, 于世家, 等. 2型糖尿病合并非酒精性脂肪肝发病机制的研究进展[J]. 基础医学与临床, 2018, 38(8): 1163-1167. [2] Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis[J]. J Hepatol, 2019, 71(4): 793-801. [3] Taylor RS, Taylor RJ, Bayliss S, et al.Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis[J]. Gastroenterology, 2020, 158(6): 1611-1625. [4] 杨薇, 李源, 杨永林. 瞬时弹性成像技术(TE)对肝纤维化诊断价值的研究进展[J]. 中西医结合心血管病电子杂志, 2018, 6(9): 29-30. [5] 冯源, 兰晓莉. 影像组学介绍[J]. 中华核医学与分子影像杂志, 2023, 43(1): 55-60. [6] 石镇维, 刘再毅. 影像组学研究的困境和出路[J]. 中华放射学杂志, 2022, 56(1): 9-11. [7] Sim KC, Kim MJ, Cho Y, et al.Diagnostic feasibility of magnetic resonance elastography radiomics analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease[J]. J Comput Assist Tomogr, 2022, 46(4): 505-513. [8] D'Souza JC, Sultan LR, Hunt SJ, et al. B-mode ultrasound for the assessment of hepatic fibrosis: a quantitative multiparametric analysis for a radiomics approach[J]. Sci Rep, 2019, 9(1): 8708. [9] American Diabetes Association.2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020[J]. Diabetes Care, 2020, 43(Suppl 1): S14-S31. [10] European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease[J]. Diabetologia, 2016, 59(6): 1121-1140. [11] Siddiqui MS, Vuppalanchi R, Van Natta ML, et al.Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol, 2019, 17(1): 156-163. [12] Singh S, Allen AM, Wang Z, et al.Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies[J]. Clin Gastroenterol Hepatol, 2015, 13(4): 643-654. [13] Lee HW, Wong GL, Kwok R, et al.Serial transient elastography examinations to monitor patients with type 2 diabetes: a prospective cohort study[J]. Hepatology, 2020, 72(4): 1230-1241. [14] Uddin S, Khan A, Hossain ME, et al.Comparing different supervised machine learning algorithms for disease prediction[J]. BMC Med Inform Decis Mak, 2019, 19(1): 281. [15] Rodríguez-Pérez R, Bajorath J.Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions[J]. J Comput Aided Mol Des, 2020, 34(10):1013-1026. [16] Delabays C, Demartines N, Joliat GR, et al.Enhanced recovery after liver surgery in cirrhotic patients: a systematic review and meta-analysis[J]. Perioper Med (Lond), 2024, 13(1):24. [17] Tacke F, Weiskirchen R.An update on the recent advances in antifibrotic therapy[J]. Expert Rev Gastroenterol Hepatol, 2018, 12(11):1143-1152. |